Evidence map›Paper›PMID 42371519›Full record

ReviewBioImpacts : BI2026

The promising applications of 3D printing technology for diagnosis and therapy of cancer: Recent advances and challenges.

Mohsen Farrokhpour, Safa Samadzadeh Etehadi, Pejman Hassanpoor, Tola Abdulsattar Faraj, Ayad H Hasan, Vesal Abbasian, Sargol Aminnezhad, Mohammadreza Azimi, Soheila Kashanian, Mehran Alavi

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in BioImpacts : BI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mohsen FarrokhpourFirouzgar Hospital, Department of Internal Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0001-6057-5437
Safa Samadzadeh EtehadiDepartment of Medicine, Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0009-0001-0454-4262
Pejman HassanpoorDepartment of Microbiology, Faculty of Basic Sciences, Rouzbahan Institute of Higher Education, Sari, Iran.ORCID https://orcid.org/0009-0008-7418-0274
Tola Abdulsattar FarajDepartment of Medical Analysis, Faculty of Applied Science, Tishk International University, Erbil, Iraq.
Ayad H HasanDepartment of Biomedical Sciences, Cihan University-Erbil, Erbil, Kurdistan Region, Iraq.ORCID https://orcid.org/0000-0001-7280-2254
Vesal AbbasianSchool of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0009-0004-6373-3188
Sargol AminnezhadDepartment of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
Mohammadreza AzimiDepartment of biochemistry, Medical Faculty, Saveh Branch, Islamic Azad University, Saveh, Iran.ORCID https://orcid.org/0000-0001-8490-2500
Soheila KashanianFaculty of Chemistry, Razi University, Kermanshah, 6714414971, Iran.
Mehran AlaviDepartment of Biological Science, Faculty of Science, University of Kurdistan, Sanandaj, Kurdistan, Iran.ORCID https://orcid.org/0000-0002-5691-8326

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Using structured materials and special molecules, scientists can create synthetic materials that can change their properties in a controlled and efficient way, resulting in useful functions. These characteristics remind us of the most popular designs found in nature. Specifically, they can produce strong structures when needed, store information, cause movement, and hold and release therapeutic agents. These macromolecular systems can be created using three-dimensional (3D) printing technology that can respond to human physiological conditions. In this review, the reasons for this progress are explained, and the potential future developments for macromolecules with specific functions are discussed. This review delves into the advancements in 3D printing technology and polymeric nanomaterials, particularly in the diagnosis and therapy of cancer. In addition, it highlights the versatility of these materials in creating intricate scaffolds with enhanced therapeutic properties, leveraging nanotechnology to improve cell interactions.

Indexed as

3D printing techniquesBiocompatibilityCancer diagnosisCancer therapyPolymeric nanomaterialsTherapeutic agents

Identifiers

PMID42371519
PMCPMC13310250

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.